RIGL
RIGEL PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$46.43
+1.26%Forward multiples
Based on analyst estimates
- P/E forward
- 13.80x
- P/E 2026E
- 13.27x
- P/E 2027E
- 9.94x
- P/E 2028E
- 7.76x
- P/S forward
- 2.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.63x
- PEG TTM
- —
- Price / book
- 2.04x
- Price / sales
- 3.13x
- Price / cash flow
- 10.92x
Enterprise value
- Enterprise value
- $811.9M
- EV / sales
- 2.93x
- EV / EBITDA
- 8.63x
- EV / EBIT
- 9.33x
- Market cap
- $867.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026